Search - tctmd.com

Displaying 161 - 180 of 187

Sort: Relevancy | Date

Presentation ESC 2012

WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI)

Presenter: Willem Dewilde

August 28, 2012

News Conference News ESC 2012

WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants

Yael L. Maxwell

August 28, 2012

News Conference News ESC 2012

Noninvasive CT Angiography Plus CT Perfusion Shows Power to Diagnose Ischemic Lesions

August 28, 2012

News Conference News ESC 2012

MADONNA: Repeat Antiplatelet Doses in Poor Responders Improves Outcomes After PCI

Caitlin E. Cox

August 28, 2012

Presentation ESC 2012

FFR-guided PCI versus Medical Therapy for Stable Cornary Disease

Presenter: Bernard De Bruyne

August 28, 2012

News Conference News ESC 2012

FAME 2: PCI Bests Medical Therapy in Stable Patients with Proven Ischemia

August 28, 2012

News Conference News ESC 2012

STEMI Patient Population Evolves Over 15 Years

Yael L. Maxwell

August 27, 2012

News Conference News ESC 2012

PCI Fails to Match CABG in Diabetic Patients with Multivessel Disease

Yael L. Maxwell

August 27, 2012

News Conference News ESC 2012

No Benefit of Intra-aortic Balloon Pump in MI Patients with Shock

August 27, 2012

News Conference News ESC 2012

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Caitlin E. Cox

August 27, 2012

News Conference News ESC 2012

Survey Reveals Improvements, Gaps in Primary PCI Access Across Europe

Jason Kahn

August 26, 2012

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

News Conference News ESC 2012

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

August 26, 2012

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Conference News

CRISP AMI: Balloon Pump Therapy Fails to Help STEMI Patients Without Shock

Jason Kahn

September 06, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

Landmark Analyses Show Downside of Prolonged Antiplatelet Therapy

September 02, 2011

News Conference News

Study Investigates Which Elderly Patients Benefit from Aggressive Treatment

September 01, 2011

News Conference News

Japanese ACS Patients Fare Better with High Rates of Intensive Treatment

September 01, 2011

News Conference News

Halting Clopidogrel in First Year Following Acute MI Hazardous

September 01, 2011

Advertisement

WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI)

WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants

Noninvasive CT Angiography Plus CT Perfusion Shows Power to Diagnose Ischemic Lesions

MADONNA: Repeat Antiplatelet Doses in Poor Responders Improves Outcomes After PCI

FFR-guided PCI versus Medical Therapy for Stable Cornary Disease

FAME 2: PCI Bests Medical Therapy in Stable Patients with Proven Ischemia

STEMI Patient Population Evolves Over 15 Years

PCI Fails to Match CABG in Diabetic Patients with Multivessel Disease

No Benefit of Intra-aortic Balloon Pump in MI Patients with Shock

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Survey Reveals Improvements, Gaps in Primary PCI Access Across Europe

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

ESC Congress 2011: Drugs, Devices Work Together

CRISP AMI: Balloon Pump Therapy Fails to Help STEMI Patients Without Shock

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

Landmark Analyses Show Downside of Prolonged Antiplatelet Therapy

Study Investigates Which Elderly Patients Benefit from Aggressive Treatment

Japanese ACS Patients Fare Better with High Rates of Intensive Treatment

Halting Clopidogrel in First Year Following Acute MI Hazardous

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content